Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Cutaneous calcinosis can be induced in young animals using certain compounds, but only in specific areas and with high mortality.

Topical calcineurin inhibitors might be safer than steroids for scarring alopecia, but more research is needed.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

UV light can help stimulate the growth of new pigment cells from hair follicles in people with vitiligo.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

The meeting concluded with optimism about increasing research and better management of vitiligo.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Cabergoline effectively treated a dog's hyperadrenocorticism.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.